Glycomics & Glycobiology Market - Global Growth Drivers by 2027

The glycomics/glycobiology market is projected to reach USD 3.7 Billion by 2027 from USD 1.8 Billion in 2022, at a CAGR of 15.5% during the forecast period.

Glycomics Market research report forecast 2022-2027 has been prepared by experienced and knowledgeable market analysts and researchers. Each section of the research study is specially prepared to explore key aspects of the industry. Buyers of the report will have access to accurate Porter’s 5 Analysis, PESTLE, SWOT, and other types of analysis on the global Glycobiology market. The report aims to provide a thorough and accurate analysis of the industry, taking into account forecast, competitive intelligence, technical risks, innovations, and other pertinent data. Readers will learn about significant opportunities in the worldwide market, as well as major factors driving and inhibiting growth.

To Understand Business Strategies, Request For a Sample PDF Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525

The glycomics/glycobiology market is expected to grow at a CAGR of 15.5% during the forecast period. The growth of the market is due to emerging use of glycans as biomarker, increased prevalence of cancer, advancing technology for glycan analysis, collaborations and partnerships among market players for the development of glycobiology products.

The Prominent players covered in the Glycomics Market are:

Key players in the glycomics/glycobiology market are Thermo Fisher Scientific (US), New England Biolabs (US), Merck KGaA (Germany), Promega Corporation (US), Waters Corporation (US), Takara Bio Inc, (Japan), Bio-Techne (US), Agilent Technologies (US), Sumitomo Bakelite Co. Ltd. (Japan), Bruker Corporation (US), Shimadzu Corporation (Japan), Danaher Corporation (US), AMS Bio (UK), Ludger Ltd (UK), Z Biotech, LLC (US), Chemily Glycoscience (US), CD BioGlyco (US), GlycoDiag (France), Kode Biotech Limited (New Zealand), Glyxera GmBH (Germany), Lectenz Bio (US), Glycomix Ltd (UK), IEC Group (Italy), Asparia Glycomics (Spain) and Ray Biotech Life Inc. (US).

Drivers: Emergence of glycans as biomarkers

Glycans play a vital role in biology; alterations in glycans can lead to dangerous consequences, such as congenital disorders, heart diseases, growth defects, and epilepsy. Research has shown that mutation in glycosyltransferases or related enzymes modifies/alters the glycome and can cause over 100 types of human congenital disorders of glycosylation.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525

Recent Developments

  • In April 2022, Bruker Corporation (US) acquired the IonSense (US) for expansion of the use of DART Mass spectrometers.
  • In April 2021, GlycoNet (Canada) and BridgeBio Pharma Inc, (US) entered into partnership for developing medicines for treating genetic diseases through glycobiology research.

North America is the fastest-growing region of the glycomics/glycobiology market in 2022.

North America is estimated to be the fastest-growing segment of the market. The growth of the glycomics/glycobiology market in this region is driven by the presence of prominent market players offering glycomics products, increasing focus on glycomics research and its application in drug development and availability of research infrastructure in the US.

Avail 10% Discount on various license types on Immediate Purchase @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=132685525

Table of Contents:

Glycomics Market Scenario 2022

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Glycomics market.

Chapter 2: Exclusive Summary – the basic information of the Glycomics Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges Opportunities of the Glycomics.

Chapter 4: Presenting the Glycomics Market Factor Analysis, Supply/Value Chain, PESTEL analysis, Market Entry, Patent/Trademark Analysis.

Chapter 5: Displaying the by Type, End User and Region/Country 2022 – 2027

Chapter 6: Evaluating the leading manufacturers of the Glycomics market which consists of its Competitive Landscape, Peer Group Analysis, Market positioning Company Profile

Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2022-2027)

Chapter 8 9: Displaying the Appendix, Methodology and Data Source

This Glycomics Market Research/Analysis Report Contains Answers to your following Questions:

  1. Who are the key players in the glycomics/glycobiology market?
  2. Which product segment dominates the glycomics/glycobiology market?
  3. Which application segment dominates the glycomics/glycobiology market?
  4. Which end user segment dominates the glycomics/glycobiology market?
  5. What is the market size for the glycomics/glycobiology market?

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:/P

An additional five company profiles


health

46 Blog posts

Comments